CIK: 0001839209 · Show all filings
Period: Q4 2020 (Next →)
Filing Date: Feb 16, 2021
Total Value ($000): $358,395 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ACCELERON PHARMA INC | 938,490 | $120,070 | 33.5% | $127.94 | — | COM | 00434H108 |
| FATE | FATE THERAPEUTICS INC | 952,847 | $86,642 | 24.2% | $62.10 | 0.0% | COM | 31189P102 |
| — | MIRATI THERAPEUTICS INC | 260,876 | $57,299 | 16.0% | $219.64 | — | COM | 60468T105 |
| BBIO | BRIDGEBIO PHARMA INC | 662,958 | $47,143 | 13.2% | $48.24 | 0.0% | COM | 10806X102 |
| SRPT | SAREPTA THERAPEUTICS INC | 114,900 | $19,589 | 5.5% | $148.17 | 0.0% | COM | 803607100 |
| IMVT | IMMUNOVANT INC | 199,269 | $9,204 | 2.6% | $46.23 | 0.0% | COM | 45258J102 |
| CCCC | C4 THERAPEUTICS INC | 228,595 | $7,573 | 2.1% | $29.00 | 0.0% | COM STK | 12529R107 |
| — | GENERATION BIO CO | 197,191 | $5,590 | 1.6% | $28.35 | — | COM | 37148K100 |
| ARVN | ARVINAS INC | 35,200 | $2,990 | 0.8% | $34.48 | 0.0% | COM | 04335A105 |
| — | INHIBRX INC | 36,534 | $1,205 | 0.3% | $32.98 | — | COM | 45720L107 |
| FULC | FULCRUM THERAPEUTICS INC | 61,313 | $718 | 0.2% | $11.31 | 0.0% | COM | 359616109 |
| STOK | STOKE THERAPEUTICS INC | 6,000 | $372 | 0.1% | $45.84 | 0.0% | COM | 86150R107 |